L-Arginine Hydrochloride

盐酸L-精氨酸

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameL-Arginine Hydrochloride
Drug Alias NameR-Gene 10
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Lysinuric Protein IntoleranceInflammation +[24
Global Approved IndicationsLysinuric Protein IntoleranceHyperammonemiaUrea Cycle Disorders, Inborn
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[10
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active IndicationsCoronavirus Disease 2019 (COVID-19)Lysinuric Protein IntoleranceHyperammonemia +[7
Inactive IndicationsInflammationGlucose IntoleranceDiabetes Mellitus, Type 2 +[17

Other Information

ATC CodeV04CD